30 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
43
Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6.

Icahn School Of Medicine At Mount Sinai
19
Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment Inhibitor.

University of Toronto
7
Discovery and structure-activity analysis of 4-((5-nitropyrimidin-4-yl)amino)benzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors.

Sichuan University
21
Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool Compound.

Epizyme
34
Selective inhibitors of protein methyltransferases.

Icahn School Of Medicine At Mount Sinai
15
Exploration of cyanine compounds as selective inhibitors of protein arginine methyltransferases: synthesis and biological evaluation.

The University of Georgia
25
Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.

University of North Carolina at Chapel Hill
13
Identifying novel selective non-nucleoside DNA methyltransferase 1 inhibitors through docking-based virtual screening.

Chinese Academy of Sciences
3
Diamidine compounds for selective inhibition of protein arginine methyltransferase 1.

The University of Georgia
4
Novel symmetrical ureas as modulators of protein arginine methyl transferases.

Universidade De Vigo
6
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2.

TBA
1
Identification of small-molecule enhancers of arginine methylation catalyzed by coactivator-associated arginine methyltransferase 1.

University of Salerno
4
Pharmacophore-based virtual screening and biological evaluation of small molecule inhibitors for protein arginine methylation.

Georgia State University
56
Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L.

Baylor College of Medicine
31
Oncoepigenomics: making histone lysine methylation count.

TBA
11
Synthesis and evaluation of carbocyanine dyes as PRMT inhibitors and imaging agents.

Georgia State University
5
Toward the development of potent and selective bisubstrate inhibitors of protein arginine methyltransferases.

University Park
23
Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1).

Bristol Myers Squibb
2
A novel arginine methyltransferase inhibitor with cellular activity.

Albert-Ludwigs-University of Freiburg
8
Target-based approach to inhibitors of histone arginine methyltransferases.

Albert-Ludwigs-University of Freiburg
25
Small molecule inhibitors of histone arginine methyltransferases: homology modeling, molecular docking, binding mode analysis, and biological evaluations.

Sapienza University of Rome
10
Novel 3,5-bis(bromohydroxybenzylidene)piperidin-4-ones as coactivator-associated arginine methyltransferase 1 inhibitors: enzyme selectivity and cellular activity.

The University of Texas M.D. Anderson Cancer Center
14
Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1.

Albert-Ludwigs-University of Freiburg
16
Discovery and mechanistic study of a class of protein arginine methylation inhibitors.

Georgia State University
31
1,2-Diamines as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1).

Methylgene
13
Benzo[d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)--Hit to Lead studies.

Bristol Myers Squibb
17
Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1).

Bristol Myers Squibb
8
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Merck Sharpe & Dohme
5
Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties

Research Triangle Institute
2
Cloning, expression, and pharmacological characterization of a novel human histamine receptor.

Smithkline Beecham Pharmaceuticals